Recursive Superintelligence Inc., a startup that hopes to develop self-improving artificial intelligence models, launched today with $650 million in funding. Alphabet Inc.’s GV fund and Greycroft led ...

I believe that a good speculative biotech to go over for the "Exclusive BAC Subscribers Article" would be Recursion (RXRX). The reason why I want to go over this biotech next is because the company ...

A global data center developer is linked to large land purchases in Caddo and Bossier parishes. Public records connect STACK Infrastructure to the acquisitions through an LLC sharing its corporate ...

Imre Szenttornyay, CEO of Cielo IT LLC, empowers business owners to scale their operations profitably with AI-powered SmartSigns technology. When you manage a network of retail or franchise locations, ...

Recursion Pharmaceuticals (RXRX) added ~11% in the morning trading on Wednesday after J.P. Morgan upgraded the AI-driven biotech to Overweight from Neutral, citing a blockbuster sales potential for ...

Dec 8 (Reuters) - Recursion Pharma (RXRX.O), opens new tab, which uses artificial intelligence to discover new drug candidates, said on Monday its experimental oral drug helped reduce abnormal growths ...

While DevOps drives innovation and simplifies collaboration, it also comes with its own set of risks and vulnerabilities. Developers rely on Git-based platforms like GitHub, Azure DevOps, Bitbucket, ...

Investors in Recursion (NASDAQ: RXRX) seemed only mildly fazed by Wednesday’s series of company announcements. The artificial intelligence (AI)-based drug developer’s stock barely moved on Wednesday, ...

LinkedIn Is Using More User Data Than Ever to Train Its AI. Here's How to Opt Out As of Nov. 3, LinkedIn is now using data from members in the EU, EEA, Switzerland, Canada, and Hong Kong to train its ...

Crews from concrete contractor Baker Concrete place Sublime Systems' low-carbon concrete in a loading dock pour on a STACK Infrastructure data center in Prince William County, Va. August 19, 2025 ...